Concenter

BioPharma

Jan 30, 20222 min read

"First-In-Man Clinical Trial – Zygosid-50 for treating T2D" - summary of results (partial)

The primary efficacy objective of the study was to demonstrate that treatment with Zygosid-50 yields a significant reduction in the...

Aug 5, 20212 min read

First Patient Dosed in Clinical Trial!

Glucometer

bottom of page